David Weinreich
Consultant / Advisor chez Foresite Capital Management LLC
Profil
David is an operating partner at Foresite Labs, and also serves as senior advisor at Foresite Capital.
With more than 20 years of expertise in clinical development, drug commercialization and advancing therapies for patients in need, David supports Foresite Labs’ incubated companies, particularly their translational and clinical research commitments, and explores and initiates new programs and company concepts.
David joined Foresite Labs from Regeneron, where he was the executive vice president and head of global clinical development.
During his tenure with the company, David managed programs across different therapeutic focus areas, including its successful Dupixent program and its COVID therapeutic antibody.
Prior to Regeneron, he was the head of global development for specialty medicine at Bayer Pharmaceuticals and previously served as executive director and global product area leader (Angiogenesis) at Amgen.
BS in Computer Engineering from Columbia University
Executive MBA from Georgetown University
MD from Boston University School of Medicine
Postes actifs de David Weinreich
| Sociétés | Poste | Début |
|---|---|---|
Foresite Capital Management LLC
 Foresite Capital Management LLC Investment ManagersFinance Foresite Capital Management LLC (Foresite Capital) is a private equity firm founded in 2010 by James Tananbaum. The firm is headquartered in San Francisco. | Consultant / Advisor | 01/08/2023 |
| Foresite Labs LLC | Private Equity Investor | 01/08/2023 |
Anciens postes connus de David Weinreich
| Sociétés | Poste | Fin |
|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | Private Equity Investor | 01/08/2023 |
| Bayer Pharmaceuticals Corp. | Private Equity Investor | 01/02/2016 |
| AMGEN INC. | Private Equity Investor | 01/06/2012 |
Gene Logic, Inc.
 Gene Logic, Inc. BiotechnologyHealth Technology Gene Logic, Inc. provides drug discovery and development services to pharmaceutical and biotechnology companies worldwide. The company operates in three segments: Genomics and Toxicogenomics Services, Preclinical Contract Research Services, and Drug Repositioning and Selection Services. Gene Logic was incorporated in 1994 and is headquartered in Gaithersburg, Maryland. | Private Equity Investor | 01/09/2005 |
Formation de David Weinreich
| The Trustees of Columbia University in The City of New York | Undergraduate Degree |
| Georgetown University | Masters Business Admin |
| Boston University School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| REGENERON PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Gene Logic, Inc.
Gene Logic, Inc. BiotechnologyHealth Technology Gene Logic, Inc. provides drug discovery and development services to pharmaceutical and biotechnology companies worldwide. The company operates in three segments: Genomics and Toxicogenomics Services, Preclinical Contract Research Services, and Drug Repositioning and Selection Services. Gene Logic was incorporated in 1994 and is headquartered in Gaithersburg, Maryland. | Health Technology |
| Bayer Pharmaceuticals Corp. | |
Foresite Capital Management LLC
Foresite Capital Management LLC Investment ManagersFinance Foresite Capital Management LLC (Foresite Capital) is a private equity firm founded in 2010 by James Tananbaum. The firm is headquartered in San Francisco. | Finance |
| Foresite Labs LLC |
